There is little information in the literature about the use of insulin Lispro in pregnancy. This study was designed 1. To assess the safety of insulin Lispro used in patients with gestational and pre-gestational diabetes mellitus and 2. To evaluate patient satisfaction...
We assessed the safety of insulin lispro in gesta- tional, type 1 and type diabetes mellitus, analysing 635 pregnancies over a period of 7 years. We also evaluated patient satisfaction, sending an internationally-accepted anonymous diabetes treatment satisfaction questionnaire to 22 patients (three typ...
borderline to a high value. Lispro and regular insulin were simulated with dosages that ranged from 0 to 6 units; the resulting GV was analyzed after each insulin injection. The numerical model used consists of a set of non-linear differential equations with two time delays and five ...
摘要: Aims: To compare the end-organ metabolic effects of insulin glulisine (glulisine), insulin lispro (lispro) and regular human insulin (RHI) in patients with type 1 diabetes mellitus.关键词:euglycaemic glucose clamp glulisine lispro ...
This study compared glycemic control achieved with insulin lispro or buffered regular human insulin in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) using an external insulin pump. In this 24-week multicenter, randomized, two-way crossover, open-label tria...
Insulin infusion therapy in critical care patients: Regular insulin vs short- acting insulin. A prospective, crossover, randomized, multicenter blind study ☆ , ☆☆ Federico Bilotta, MD, PhD a, ⁎, Rafael Badenes, MD b , Simona Lolli, MD a , Francisco Javier Belda, MD b , Sharon Ein...
Effects of a short-acting insulin analog (insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus Metabolism Volume 47, Issue 4, April 1998, Pages 371-376 Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor...
The postprandial increases in nitrotyrosine levels were significantly less after VIAject than after human regular insulin (VIAject -0.22 +/- 0.17 vs. human insulin 0.25 +/- 0.15 microg/ml; P < 0.05), whereas nitrotyrosine after insulin lispro was in between (insulin lispro 0.09 +/- 0.07 ...
Within-person day-to-day variation in plasma glucose was lower with insulin detemir/insulin aspart than with NPH in- sulin/regular human insulin (SD: 2.88 vs 3.12 mmol/l; p<0.001). Risk of overall and nocturnal hypogly- caemia (23.00–06.00 hours) was, respectively, 21% (p=0.036) and...
Total insulin requirements were lower in the lispro group in the first (0.58 vs. 0.79 units/kg, p = 0.02), second (0.75 vs. 1.10 units/kg, p = 0.002), and third (0.98 vs. 1.25 units/kg, p = 0.03) trimesters of pregnancy. Mean infant birth weight was greater in the lispro ...